161 related articles for article (PubMed ID: 35626301)
1. Ex Vivo Fluorescence Confocal Microscopy (FCM) of Prostate Biopsies Rethought: Opportunities of Intraoperative Examinations of MRI-Guided Targeted Biopsies in Routine Diagnostics.
Sievert KD; Hansen T; Titze B; Schulz B; Omran A; Brockkötter L; Gunnemann A; Titze U
Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626301
[TBL] [Abstract][Full Text] [Related]
2. Ex Vivo Fluorescence Confocal Microscopy of MRI-Guided Targeted Prostate Biopsies for Rapid Detection of Clinically Significant Carcinomas-A Feasibility Study.
Titze U; Titze B; Hansen T; Barth PJ; Ali FA; Schneider F; Benndorf M; Sievert KD
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473235
[TBL] [Abstract][Full Text] [Related]
3. Feasibility study for
Titze U; Hansen T; Titze B; Schulz B; Gunnemann A; Rocco B; Sievert KD
Quant Imaging Med Surg; 2021 Apr; 11(4):1322-1332. PubMed ID: 33816171
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Performance of Ex Vivo Fluorescence Confocal Microscopy in the Assessment of Diagnostic Biopsies of the Prostate.
Titze U; Hansen T; Brochhausen C; Titze B; Schulz B; Gunnemann A; Rocco B; Sievert KD
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830839
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
6. Ex Vivo Fluorescence Confocal Microscopy (FCM) Ensures Representative Tissue in Prostate Cancer Biobanking: A Feasibility Study.
Titze U; Sommerkamp J; Stege C; Schneider F; Brochhausen C; Schulz B; Titze B; Abd Ali F; Pokupic S; Sievert KD; Hansen T
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292970
[TBL] [Abstract][Full Text] [Related]
7. Digital Biopsy with Fluorescence Confocal Microscope for Effective Real-time Diagnosis of Prostate Cancer: A Prospective, Comparative Study.
Rocco B; Sighinolfi MC; Sandri M; Spandri V; Cimadamore A; Volavsek M; Mazzucchelli R; Lopez-Beltran A; Eissa A; Bertoni L; Azzoni P; Reggiani Bonetti L; Maiorana A; Puliatti S; Micali S; Paterlini M; Iseppi A; Rocco F; Pellacani G; Chester J; Bianchi G; Montironi R
Eur Urol Oncol; 2021 Oct; 4(5):784-791. PubMed ID: 32952095
[TBL] [Abstract][Full Text] [Related]
8. Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial.
Tonttila PP; Lantto J; Pääkkö E; Piippo U; Kauppila S; Lammentausta E; Ohtonen P; Vaarala MH
Eur Urol; 2016 Mar; 69(3):419-25. PubMed ID: 26033153
[TBL] [Abstract][Full Text] [Related]
9. Ex Vivo Fluorescence Confocal Microscopy for Intraoperative Examinations of Lung Tumors as Alternative to Frozen Sections-A Proof-of-Concept Study.
Kamm M; Hildebrandt F; Titze B; Höink AJ; Vorwerk H; Sievert KD; Groetzner J; Titze U
Cancers (Basel); 2024 Jun; 16(12):. PubMed ID: 38927926
[TBL] [Abstract][Full Text] [Related]
10. Current applications of ex-vivo fluorescent confocal microscope in urological practice: a systematic review of literature.
Eissa A; Puliatti S; Rodriguez Peñaranda N; Resca S; Di Bari S; Vella J; Maggiorelli S; Bertoni L; Azzoni P; Reggiani Bonetti L; Campobasso D; Ferretti S; Micali S; Bianchi G
Chin Clin Oncol; 2024 May; ():. PubMed ID: 38769791
[TBL] [Abstract][Full Text] [Related]
11. Are concurrent systematic cores needed at the time of targeted biopsy in patients with prior negative prostate biopsies?
Albisinni S; Aoun F; Noel A; El Rassy E; Lemort M; Paesmans M; van Velthoven R; Roumeguère T; Peltier A
Prog Urol; 2018 Jan; 28(1):18-24. PubMed ID: 29203158
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H;
Lancet Oncol; 2021 Sep; 22(9):1240-1249. PubMed ID: 34391509
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Fluorescent Confocal Microscopy for Intraoperative Analysis of Prostate Biopsy Cores.
Marenco J; Calatrava A; Casanova J; Claps F; Mascaros J; Wong A; Barrios M; Martin I; Rubio J
Eur Urol Focus; 2021 Nov; 7(6):1254-1259. PubMed ID: 32912840
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies.
Arsov C; Rabenalt R; Blondin D; Quentin M; Hiester A; Godehardt E; Gabbert HE; Becker N; Antoch G; Albers P; Schimmöller L
Eur Urol; 2015 Oct; 68(4):713-20. PubMed ID: 26116294
[TBL] [Abstract][Full Text] [Related]
15. Current and future perspectives of digital microscopy with fluorescence confocal microscope for prostate tissue interpretation: a narrative review.
Rocco B; Cimadamore A; Sarchi L; Bonetti LR; Bertoni L; Azzoni P; Assumma S; Turri F; Bozzini G; Eissa A; Micali S; Bianchi G; Maiorana A; Montironi R; Pellacani G; Sighinolfi MC
Transl Androl Urol; 2021 Mar; 10(3):1569-1580. PubMed ID: 33850791
[TBL] [Abstract][Full Text] [Related]
16. Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate?
Exterkate L; Wegelin O; Barentsz JO; van der Leest MG; Kummer JA; Vreuls W; de Bruin PC; Bosch JLHR; van Melick HHE; Somford DM
Eur Urol Oncol; 2020 Apr; 3(2):216-223. PubMed ID: 31239236
[TBL] [Abstract][Full Text] [Related]
17. Analysis of histological findings obtained combining US/mp-MRI fusion-guided biopsies with systematic US biopsies: mp-MRI role in prostate cancer detection and false negative.
Faiella E; Santucci D; Greco F; Frauenfelder G; Giacobbe V; Muto G; Zobel BB; Grasso RF
Radiol Med; 2018 Feb; 123(2):143-152. PubMed ID: 29019021
[TBL] [Abstract][Full Text] [Related]
18. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?
Wegelin O; van Melick HHE; Hooft L; Bosch JLHR; Reitsma HB; Barentsz JO; Somford DM
Eur Urol; 2017 Apr; 71(4):517-531. PubMed ID: 27568655
[TBL] [Abstract][Full Text] [Related]
19. Ex Vivo Fluorescence Confocal Microscopy in Specimens of the Liver: A Proof-of-Concept Study.
Titze U; Sievert KD; Titze B; Schulz B; Schlieker H; Madarasz Z; Weise C; Hansen T
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158859
[TBL] [Abstract][Full Text] [Related]
20. Targets missed: predictors of MRI-targeted biopsy failing to accurately localize prostate cancer found on systematic biopsy.
Coker MA; Glaser ZA; Gordetsky JB; Thomas JV; Rais-Bahrami S
Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):549-555. PubMed ID: 29988101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
